Home » Duke Using Illumina GA to Study HIV Resistance

Duke Using Illumina GA to Study HIV Resistance

Jan 12, 2009

NEW YORK (GenomeWeb News) — Duke University will use Illumina's Genome Analyzer to search for genetic variations that may enable some people to be resistant to HIV infections, the company said today.

Researchers at the Center for Human Genome Variation at Duke's Institute for Genome Sciences and Policy will use the technology to sequence the complete genome of at least 50 individuals.

Financial terms of the agreement were not released.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Scan

Dual Listings Sought

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

Allocating the Grant Pie

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

More Proposed for NSF

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

This Week in PNAS

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.

Jun
28
Featured Webinar

An Optimized NGS Workflow for Human Metagenomic Analysis

Sponsored by
PerkinElmer

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.

What's Popular?

In Clinical Sequencing

  1. Roche to Acquire Outstanding Shares of Foundation Medicine for $2.4B

  2. Mayo Team Describes Clinical RNA Sequencing Assay for Oncogenic Fusions

    Premium

  3. Natera, Institut Jules Bordet Ink Breast Cancer Research Collaboration

  4. Comprehensive Genetic Testing in Patients With Multiple Tumors Detects Additional Risk Variants

  5. Targeted Gene Panel Could Cost-Effectively Diagnose Movement Disorders, Consortium Finds

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.